Creative Planning’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Creative Planning’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,000	Closed	-$45K	–	5144
2016 Q3	$45K	Hold	5,000	–	–	﹤0.01%	2454
2016 Q2	$27K	Hold	5,000	–	–	﹤0.01%	2591
2016 Q1	$23K	Sell	5,000 -4,000	-44%	-$16.1K	﹤0.01%	2675
2015 Q4	$47K	Buy	+9,000	New	+$52.2K	﹤0.01%	2178
2014 Q2	–	Sell	-2,000	Closed	-$20K	–	4200
2014 Q1	$20K	Hold	2,000	–	–	﹤0.01%	2394
2013 Q4	$26K	Hold	2,000	–	–	﹤0.01%	2043
2013 Q3	$30K	Hold	2,000	–	–	﹤0.01%	1865
2013 Q2	$19K	Buy	+2,000	New	+$13.5K	﹤0.01%	1983

Creative Planning's RPTP Position: Q4 2016 in Review

Creative Planning sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 5,000 shares — an estimated $45K sold.

Creative Planning first reported a position in RPTP in Q2 2013 and held it in 8 quarters. The position peaked at $47K in Q4 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

Creative Planning reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
Creative Planning sold 5,000 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $45K.
Creative Planning first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 8 quarters.
Creative Planning's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $47K in Q4 2015.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Creative Planning's 13F filing for Q4 2016, filed 9 Jan 2017.